Many of the biggest impacts of technology have been driven by monopolies and their network effects. The question is what kind of monopoly we choose, and what impacts our choices create. When we choose open standards as our monopolies, we get vast open networks – HTML, TCP/IP, and other systems where anyone can compete. When we choose walled gardens as our monopolies, we get a very different results – Apple, Facebook, and Twitter control precisely how and when competition and entrepreneurship can happen. We’re faced with this choice right now, and the decisions we make will define the next twenty years of technology in health.
John Wilbanks works on open content, open data, and open innovation systems. He is a Senior Fellow at the Kauffman Foundation and a Research Fellow at Lybba. He’s worked at Harvard Law School, MIT’s Computer Science and Artificial Intelligence Laboratory, the World Wide Web Consortium, the US House of Representatives, and Creative Commons, as well as starting a bioinformatics company. He sits on the Board of Directors for Sage Bionetworks, iCommons, and 1DegreeBio, and the Advisory Board for Boundless Learning. John holds a degree in philosophy from Tulane University and also studied modern letters at the University of Paris (La Sorbonne).
For information on exhibition and sponsorship opportunities at the conference, contact Sharon Pierce at (203) 304-9476 or email@example.com
For information on trade opportunities with O'Reilly conferences contact mediapartners
For media-related inquiries, contact Maureen Jennings at firstname.lastname@example.org
View a complete list of Strata Rx contacts